Roivants mission is to systematically reduce the time, cost, & risk of delivering new medicines to market by accelerating the development of promising drug candidates to improve the lives of patients & their families. The company is privately held, has in-licensed 25+ assets, & is very well-capitalized. The Corporate Development team is responsible for generating, pursuing, & leading all strategic mergers, acquisitions, & collaborations on behalf of the Vant family of portfolio companies.
Since its inception in 2014, Roivant Sciences has sought to improve health by rapidly delivering innovative medicines & technologies to patients. Weve employed a unique, decentralized model of nimble, focused companies (Vants) focused on various therapeutic areas & built around the pursuit of innovation in drug development. Roivants model has established a proven record of efficient drug development & company creation, with results including>45 drugs in development, 5 successful IPOs, 4 successful Phase 3 readouts in 2019, & 3 marketed healthcare technology software products. In late 2019, Roivant concluded a major transaction with Japans Sumitomo Dainippon Pharma (DSP), in which DSP paid $3bn to acquire Roivants interest in 5 of the Vants it had previously built, as well as taking an 11% equity stake in Roivant itself & gaining access to select proprietary Roivant technology & other IP. This transaction was led by the Corporate Development team, where the role outlined in this job description sits. The sale of these Vants & technology assets represented over a 5x return on Roivants investment.
Leveraging this proven model, we are evolving our mission & expanding capabilities to become a leader in novel modalities of drug development, & further establishing our position as the leading technology-enabled pharma company. We will redouble focus on acquiring potentially transformative assets in high-value areas, while simultaneously augmenting the conventional in-licensing model with capabilities in computational methods of drug discovery & tech-enabled development.
Today the Roivant family of companies spans therapeutics-focused Vants across a range of disease areas with robust pipelines, as well as data- & computational-focused capabilities in asset identification through drug development & commercialization: VantAI: applying AI to in silico drug discovery; DrugOme: enabling data-driven drug evaluation & trial design; Lokavant: real-time data to optimize trial operations; Datavant: de-identified patient-level health data.
Roivant is privately held & very well-capitalized.
Position Title: Principal, Corporate Development
Position Location: New York, NY
Reports To: Head of Corporate Development (Office of the CFO)
Position Summary: The individual in this position will collaborate with Corporate Development colleagues to source, evaluate, analyze, & pitch multiple transaction theses. This includes working on meaningful deal workstreams, including due diligence, financial modeling, & communications. This role will have meaningful exposure to leadership at Roivant & across the Vant family of companies & provides opportunities for capable individuals to quickly take on broader responsibility within the Corporate Development function.
Ideal candidates are likely to have had significant strategy, investing, and/or transaction experience in Healthcare (ideally therapeutics).
- Evaluate industry landscape to generate leads for potential M&A opportunities across the Vant family of companies
- Engage & form strong relationships with potential partners & advisors across the life sciences & healthcare landscape
- Conduct in-depth scientific, clinical & market research & financial modeling to support recommendations
- Lead teams of 1-3 analysts & associates
- Construct persuasive transaction theses using Excel models & PowerPoint
- Pitch transaction theses directly to senior management
- Advance transaction theses & discussions with counterparties
Skills, Qualifications, & Requirements:
- 3+ years experience in an investment banking role or a comparable position combining analytical, operational, & strategic skill sets
- Strong financial modeling capabilities, including typical valuation methods & understanding of financial fundamentals required
- Knowledge of M&A transaction processes & experience supporting such processes
- Strategic understanding of pharmaceutical & biotechnology industries
- Excellent written & verbal communication skills
- Ability to work independently & collaboratively in a fast-paced, matrixed team environment consisting of internal & external team members
- Ability to generate action through influence & engagement
- Analytical thinker with excellent problem-solving skills & the ability to adapt to changing priorities & deadlines
- Excellent planning, organization & time management skills including the ability to support & prioritize multiple projects
- Bachelors degree required